These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 20712392)
1. Cost sharing, adherence, and health outcomes in patients with diabetes. Gibson TB; Song X; Alemayehu B; Wang SS; Waddell JL; Bouchard JR; Forma F Am J Manag Care; 2010 Aug; 16(8):589-600. PubMed ID: 20712392 [TBL] [Abstract][Full Text] [Related]
2. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391 [TBL] [Abstract][Full Text] [Related]
3. Treatment satisfaction of diabetic patients: what are the contributing factors? Biderman A; Noff E; Harris SB; Friedman N; Levy A Fam Pract; 2009 Apr; 26(2):102-8. PubMed ID: 19254969 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus. Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392 [TBL] [Abstract][Full Text] [Related]
5. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO; Barner JC; Rascati KL; Strassels SA Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [TBL] [Abstract][Full Text] [Related]
6. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462 [TBL] [Abstract][Full Text] [Related]
7. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper. Breitscheidel L; Stamenitis S; Dippel FW; Schöffski O J Med Econ; 2010 Mar; 13(1):8-15. PubMed ID: 19947905 [TBL] [Abstract][Full Text] [Related]
8. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Hansen RA; Farley JF; Droege M; Maciejewski ML Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679 [TBL] [Abstract][Full Text] [Related]
9. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Cheong C; Barner JC; Lawson KA; Johnsrud MT Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Pittman DG; Tao Z; Chen W; Stettin GD Am J Manag Care; 2010 Aug; 16(8):568-76. PubMed ID: 20712390 [TBL] [Abstract][Full Text] [Related]
11. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222 [TBL] [Abstract][Full Text] [Related]
12. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288 [TBL] [Abstract][Full Text] [Related]
13. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Makary MA; Clark JM; Shore AD; Magnuson TH; Richards T; Bass EB; Dominici F; Weiner JP; Wu AW; Segal JB Arch Surg; 2010 Aug; 145(8):726-31. PubMed ID: 20713923 [TBL] [Abstract][Full Text] [Related]
14. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200 [TBL] [Abstract][Full Text] [Related]
15. Part D coverage gap and adherence to diabetes medications. Gu Q; Zeng F; Patel BV; Tripoli LC Am J Manag Care; 2010; 16(12):911-8. PubMed ID: 21348561 [TBL] [Abstract][Full Text] [Related]
16. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. Devine S; Vlahiotis A; Sundar H J Med Econ; 2010; 13(2):203-11. PubMed ID: 20345227 [TBL] [Abstract][Full Text] [Related]
17. Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE). Karter AJ; Parker MM; Solomon MD; Lyles CR; Adams AS; Moffet HH; Reed ME Health Serv Res; 2018 Apr; 53(2):1227-1247. PubMed ID: 28474736 [TBL] [Abstract][Full Text] [Related]
18. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916 [TBL] [Abstract][Full Text] [Related]
19. Economic models in type 2 diabetes. Yi Y; Philips Z; Bergman G; Burslem K Curr Med Res Opin; 2010 Sep; 26(9):2105-18. PubMed ID: 20642392 [TBL] [Abstract][Full Text] [Related]
20. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Asche C; LaFleur J; Conner C Clin Ther; 2011 Jan; 33(1):74-109. PubMed ID: 21397776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]